Ketamine promotes breast tumor growth in a mouse breast tumor model involving with high expression of miR-27b-3p and EGFR
- PMID: 35943683
- DOI: 10.1007/s10637-022-01291-x
Ketamine promotes breast tumor growth in a mouse breast tumor model involving with high expression of miR-27b-3p and EGFR
Abstract
Non-medical use of ketamine as an adulterant to ecstasy is more prevalent than amphetamine in Taiwan. Ketamine's effect on immunosuppression might play some functional role in tumor growth, while it is still controversial whether ketamine abuse could increase tumor growth or not. This study aimed to investigate the influence of ketamine addiction in breast tumors and related gene expressions. The effect of ketamine treatment on proliferation, colony formation, migration, and invasion of triple-negative breast cancer cell line EO771 was examined. In addition, a ketamine addiction mice model was established by intraperitoneal injection (IP) of ketamine in mice and used to investigate the effects of ketamine addiction on tumor growth and the possible mechanisms. In the in vitro studies, ketamine treatment at different concentrations did not affect EO771 cell proliferation and colony formation. But ketamine did enhance migration and invasion of EO771 cells. The in vivo experiments showed significantly increased breast tumor volume and weight in ketamine-addicted mice than in normal saline groups. miR-27b-3p level, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor (EGFR) significantly increased in tumors of ketamine addiction mice compared to control mice. In vivo evidence showed that Ketamine might increase tumor growth on the tumor microenvironment, and miR-27b-3p, HER2, and EGFR might play a role in the process.
Keywords: Breast cancer biomarker; Epidermal growth factor receptor; Ketamine; miR-27b-3p.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.Cell Death Dis. 2017 Jul 13;8(7):e2928. doi: 10.1038/cddis.2017.325. Cell Death Dis. 2017. PMID: 28703807 Free PMC article.
-
Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.Cancer Lett. 2019 Mar 1;444:105-115. doi: 10.1016/j.canlet.2018.12.008. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583076
-
The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.Aging (Albany NY). 2021 Jun 14;13(12):16341-16352. doi: 10.18632/aging.203160. Epub 2021 Jun 14. Aging (Albany NY). 2021. PMID: 34126594 Free PMC article.
-
Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.Cell Death Dis. 2016 Nov 3;7(11):e2454. doi: 10.1038/cddis.2016.361. Cell Death Dis. 2016. PMID: 27809310 Free PMC article.
-
miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.J Exp Clin Cancer Res. 2015 Nov 14;34:139. doi: 10.1186/s13046-015-0253-3. J Exp Clin Cancer Res. 2015. PMID: 26576539 Free PMC article.
Cited by
-
Perioperative Ketamine and Cancer Recurrence: A Comprehensive Review.J Clin Med. 2024 Mar 26;13(7):1920. doi: 10.3390/jcm13071920. J Clin Med. 2024. PMID: 38610685 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous